Our research focuses on the molecular and cellular mechanisms behind the process of vascular remodeling in Pulmonary Hypertension (PH).
Joined October 2022
- Tweets 55
- Following 127
- Followers 111
- Likes 96
15 Photos and videos
Guignabert’s Team retweeted
1 Jul 2024
Whaou! Toujours plus!
1 Jul 2024
1.700 PARTICIPANTS!!! thank you everybody for attending this wonderfull meeting #WSPH2024
4
7
353
Guignabert’s Team retweeted
9 Mar 2024
1
2
21
908
Guignabert’s Team retweeted
13 Oct 2023
Les Journées de Recherche Respiratoire #J2R ouvrent leurs portes avec une bouffée d'enthousiasme scientifique! 🌬️ Plongeons ensemble dans l'univers fascinant de la respiration, où la science respire l'innovation !!! 💡 @Inserm @UnivParisSaclay @SPLF_SocPneumo
1
8
35
1,499
Guignabert’s Team retweeted
6 Oct 2023
🔴 [#JRFHTP] Session IV : le Dr Étienne Marie Jutant @CHU_de_Poitiers intervient sur l’#HTAP avec phénotypes respiratoires et leurs caractéristiques : sexe masculin, plus âgé, DLCO basse, présence de comorbidités ⤵️
3
9
751
Guignabert’s Team retweeted
5 Oct 2023
Journées du réseau français de l’HTP: le Pr @LaurentBertole1 est dans la place pour une superbe overview des innovations thérapeutiques dans l’HTAP. @pulmotension @RespiFIL @HTaPFrance
2
12
408
Guignabert’s Team retweeted
5 Oct 2023
🔴 [#JRFHTP] Session III : Le Pr. @SavaleL présente différentes études pour appuyer l'algorithme de prise en charge des patients #HTAP ayant des #comorbidités cardiovasculaires 🫀 @pulmotension
1
5
287
Guignabert’s Team retweeted
5 Oct 2023
🔴 [#JRFHTP] Session I : Le Dr. Christophe Guignabert évoque la possibilité du #remodelage vasculaire pulmonaire dans l'#HTP et notamment l'implication de la voie BMP/TGF-β @pulmotension @InsermU999
4
5
340
Guignabert’s Team retweeted
5 Oct 2023
Lancement des Journées du réseau français de l’hypertension pulmonaire @pulmotension @InsermU999 @RespiFIL @SPLF_SocPneumo
1
6
15
665
Guignabert’s Team retweeted
11 Sep 2023
6
22
732
Guignabert’s Team retweeted
4 Jul 2023
HPS is an underdiagnosed devastating complication of chronic liver disease that can lead to liver transplantation, regardless of the severity of disease. Its detection and diagnostic approach must be rigorous. @SavaleL @ACoilly @GuignabertLab @OSitbon bit.ly/ERSM100
4
13
2,467
Guignabert’s Team retweeted
30 Jun 2023
Bravo à Fabien Robert pour avoir remporté le prix de la #meilleure présentation orale à la journée de l’école doctorale IFTA ! Il a présenté son projet de thèse :Rôle du BMP9 dans le syndrome hépatopulmonaire
@InsermU999 @UnivParisSaclay @InsermIDF
2
6
15
678
23 May 2023
Very proud of our post-doc student @NihelBerrebeh01 as she received the Assembly on Pulmonary Circulation 2023 abstract scholarship ,funded by the American Thoracic Society, congratulations 🎉 ! @InsermU999 @InsermIDF #ATS2023 #pulmonaryresearch #PAH #HTAP #CTEPH
4
11
635
22 May 2023
Welcome to @AleBiCuomo as she joins the @GuignabertLab for a year !Alessandra recieved the Heart Failure Association scolarship and will be working on CTEPH biomarkers 🫁
#CTEPH #PAH #HTAP @InsermU999 @InsermIDF
1
1
8
245
22 May 2023
Congrats to @AthenaisBoucly for recieving the ATS International Travel Scolarship Award for her work on PAH treatment strategy. @InsermU999
@InsermIDF #PAH #HTAP
3
10
54
2,097
Guignabert’s Team retweeted
12 May 2023
📃Our paper is out on how activation of #TGF-beta receptor signaling promotes #melanoma metastatic outgrowth in liver: lnkd.in/ertgPDm9
3
12
997
Guignabert’s Team retweeted
25 Apr 2023
We're thrilled to share our latest research in Circulation Journal, which demonstrates the important role of activin A and FSTL3 in predicting negative outcomes for PAH patients. Exciting news for patient care!
2
24
56
7,443
Guignabert’s Team retweeted
26 Apr 2023
This important study from @GuignabertC @GuignabertLab reveals that INHBA and FSTL3 are prognostic biomarkers of IPAH, lending more support for the concept that dysregulated activin axis signaling is a major driver and therapeutic target of PAH.
25 Apr 2023
Congratulations @GuignabertLab on this outstanding study published in Circulation. New insights into the activin signaling system and identification of new biomarkers (activin A and FSTL3) in #PAH @AthenaisBoucly @SavaleL @InsermU999 @pulmotension ahajournals.org/doi/abs/10.1…
1
2
12
1,088